4-氨基苯-1,3-二醇 | 13066-95-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 4-氨基苯-1,3-二醇
• 英文名称: 4-aminoresorcinol
• 英文别名: 4-Amino-resorcin；4-aminobenzene-1,3-diol；2,4-dihydroxyaniline
• CAS: 13066-95-0
• 化学式: C₆H₇NO₂
• mdl: MFCD19159567
• 分子量: 125.127
• InChiKey: ROCVGJLXIARCAC-UHFFFAOYSA-N

物化性质

• 熔点：
  218 °C
• 沸点：
  345.2±12.0 °C(Predicted)
• 密度：
  1.412±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.5
• 氢给体数：
  3
• 氢受体数：
  3

安全信息

• 海关编码：
  2922299090
• 储存条件：
  应存于密封、干燥、避光的室温环境中。

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  4-亚硝基间苯二酚	4-nitroso-1,3-benzenediol	698-31-7	C6H5NO3	139.111
  苏丹橙G	4-(phenylazo)-1,3-benzenediol	2051-85-6	C12H10N2O2	214.224

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  ——	2',4'-Dihydroxy-4-amino-azobenzol	91397-21-6	C12H11N3O2	229.238

反应信息

• 作为反应物：
  描述：

  4-氨基苯-1,3-二醇 在 盐酸 、 sodium ethanolate 、 sodium nitrite 作用下， 以 水 为溶剂， 生成
  参考文献：
  名称：

  Exploration of antimicrobial and antioxidant potential of newly synthesized 2,3-disubstituted quinazoline-4(3H)-ones

  摘要：

  A series of 2-(chloromethyl)-3-(4-methyl-6-oxo-5-[(E)-phenyldiazenyl]-2-thioxo-5,6-dihydropyrimidine-1(2H)-yl)quinazoline-4(3H)-ones 9a-j was synthesized by treating 2-(chloroacetyl) amino benzoic acid with 3-amino-6-methyl-5-[(E)-phenyldiazenyl]-2-thioxo-2,5-dihydropyrimidine-4(3H)-one 8a-j and was screened for in vitro antibacterial activities against a representative panel of Gram-positive and Gram-negative bacteria. The compounds were synthesized in excellent yields and the structures were corroborated on the basis of IR, H-1 NMR, Mass and elemental analysis data. All the synthesized compounds elicited the potent inhibitory action against all the tested bacterial stains. Furthermore, in order to explore the antioxidant potential of newly synthesized compounds, the free radical scavenging activity measurement were performed by the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay method. It is revealed from the antioxidant screening results that the compounds 9c and f manifested profound antioxidant potential. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.05.031
• 作为产物：
  描述：

  苏丹橙G 在 盐酸 、 tin(ll) chloride 作用下， 生成 4-氨基苯-1,3-二醇
  参考文献：
  名称：

  Meyer,R.; Kreis, Chemische Berichte, 1883, vol. 16, p. 1330

  摘要：

  DOI：

文献信息

• Npy antagonists, preparation and uses
  申请人：Botez Iuliana

  公开号：US20090233910A1

  公开（公告）日：2009-09-17

  The present invention concerns novel compounds, their preparation and their uses, therapeutic uses in particular. More specifically it concerns derivative compounds having at least two aromatic cycles, their preparation and their uses, in particular in the area of human or animal health. These compounds have an affinity for the biological receptors of neuropeptide Y, NPY, present in the central and peripheral nervous systems. The compounds of the invention are preferably NPY antagonists, and more particularly antagonists of sub-type NPY Y1, and can therefore be used for the therapeutic or prophylactic treatment of any disorder involving NPY. The present invention also concerns pharmaceutical compositions containing said compounds, their preparation and their uses, as well as treatment methods using said compounds.

  本发明涉及新颖化合物，它们的制备和用途，特别是在治疗方面的用途。更具体地说，它涉及至少具有两个芳香环的衍生化合物，它们的制备和用途，特别是在人类或动物健康领域。这些化合物对存在于中枢和外周神经系统中的神经肽Y（NPY）的生物受体具有亲和力。本发明的化合物优选为NPY拮抗剂，更具体地说是NPY Y1亚型的拮抗剂，因此可用于治疗或预防涉及NPY的任何疾病。本发明还涉及含有所述化合物的药物组合物，其制备和用途，以及使用所述化合物的治疗方法。
• HAIR COLORING COMPOSITIONS
  申请人：——

  公开号：US20020032933A1

  公开（公告）日：2002-03-21

  A hair coloring composition comprising: (a) from about 0.0003 moles (per 100 g of composition) to less than about 0.09 moles (per 100 g of composition) of an inorganic peroxygen oxidizing agent; and (b) an oxidative hair coloring agent; wherein the pH of each of (a) and (b) is in the range of from about 1 to about 6 and wherein the combined mixture of (a) and (b) has a pH in the range of from about 1 to about 6. The products can provide excellent hair coloring and in-use efficacy benefits including excellent initial color and good wash fastness in combination with reduced hair damage at low pH.

  一种染发组合物，包括：(a)约0.0003摩尔（每100克组合物）至约0.09摩尔（每100克组合物）的无机过氧化氧化剂；和(b)氧化性染发剂；其中(a)和(b)的pH值在约1至约6的范围内，且(a)和(b)的混合物的pH值在约1至约6的范围内。该产品可以提供出色的染发效果和使用效果，包括出色的初始颜色和良好的耐洗性，同时在低pH值下减少头发损伤。
• Hair colouring and conditioning compositions
  申请人：The Procter & Gamble Company

  公开号：US20030113286A1

  公开（公告）日：2003-06-19

  A hair colouring and conditioning composition comprising: (a) a hair colouring agent; and (b) a hair conditioning agent; wherein the composition provides an Average Combing Index Value of greater than 1.2 as measured by the Combing Technical Test Method. The products can provide excellent hair colouring together with excellent conditioning, reduced hair damage, brittleness and dryness, and is convenient and easy to use.

  一种包括： (a) 染发剂；和 (b) 护发剂； 的染发和护理组合物； 其中该组合物通过梳理技术测试方法测得的平均梳理指数值大于1.2。 该产品可以提供优秀的染发效果以及优秀的护理效果，减少头发损伤、脆弱和干燥，且使用方便。
• 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING
  申请人：Sutton C James

  公开号：US20080045528A1

  公开（公告）日：2008-02-21

  Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.

  苯并噁唑和苯并噻唑化合物及其立体异构体、互变异构体、溶剂合物、氧化物、酯类和前药以及其药学上可接受的盐已被披露。所述化合物的组合物，无论是单独使用还是与至少一种额外治疗剂组合，并与药学上可接受的载体一起使用的用途也已被披露。这些实施例可用于抑制细胞增殖，抑制肿瘤的生长和/或交换反应，治疗或预防癌症，治疗或预防类风湿性关节炎等退行性骨病，以及/或抑制CSF-1R等分子。
• Aggregation of blood platelets in static magnetic fields
  作者：M. Iwasaka、M. Takeuchi、S. Ueno

  DOI：10.1109/20.908952

  日期：——

  We investigated the effects of intense magnetic fields on the blood platelet aggregation process with and without static magnetic fields of up to 14 T. A rabbit plasma and collagen mixture was used as the model system for a wounded blood vessel. Platelet aggregation was activated by the stimulation of acid soluble collagen. The platelet aggregates in strong magnetic fields were larger than the aggregates in an ambient field. An optical transmission of blood plasma during platelet aggregation also indicated that strong magnetic fields enhanced blood platelet aggregation in plasma.

  我们研究了高达14特斯拉的强磁场对血小板聚集过程的影响，并对比了有无静磁场的情况。使用兔血浆和胶原蛋白混合物作为受损血管的模型系统。通过激活酸溶性胶原蛋白来触发血小板聚集。在强磁场中的血小板聚集物比在自然环境场中的更大。在血小板聚集过程中，血浆的光学透射也表明强磁场增强了血浆中的血小板聚集。